From rss.biospace.com
()
GlaxoSmithKline Plc and Takeda Pharmaceutical Co. Ltd. said they are unlikely to build in-house diagnostic divisions like Roche Holding AG, which is bidding to take over a U.S. maker of gene-mapping tools. The tandem of diagnostics and therapeutics is a logical tandem and will be very important in the future, said Tachi Yamada, chief medical and scientific officer of Osaka, Japan- based Takeda, in...
- How the Wheels Came off GlaxoSmithKline's Bus (api.bing.com)
Pharmaceutical giant GlaxoSmithKline has agreed to settle several product liability cases involving its blockbuster diabetes drug Avandia, spokeswoman Bernadette King confirmed Thursday. The company will make payments out of cash already designated to claims involving Avandia.
GlaxoSmithKline (NYSE: GSK), which has been facing legal issues relating to Avandia for years, has its North American headquarters in Research Triangle Park and employs...
From bizjournals.com
()
- GSK posts profits, shakes up R&D (api.bing.com)
Nadrich & Cohen, LLP reports that GlaxoSmithKline has agreed to settle approximately 20,000 Avandia side effects lawsuits.
Los Angeles, CA, February 3, 2012 – UK drug-maker GlaxoSmithKline has agreed to settle 20,000 Avandia side effects lawsuits. According to a Bloomberg
More perspectives...
From openpr.com
()
GlaxoSmithKline Plc (GSK), which is paying $3 billion to resolve government claims that it illegally marketed drugs such as the Avandia diabetes medication, agreed to settle more lawsuits over the pills, a lawyer said. Glaxo, the U.K.’s ...
From api.bing.com
()
- Glaxo Settles 20,000 Lawsuits Over Avandia, Lawyer Says (api.bing.com)
- Glaxo sees growth ahead after swinging to profit (api.bing.com)
GlaxoSmithKline Plc (GSK), which is paying $3 billion to resolve government claims that it illegally marketed drugs such as the Avandia diabetes medication, agreed to settle more lawsuits over the pills, a lawyer said. Glaxo, the U.K.s biggest drugmaker, agreed last month to resolve more than 20,000 cases alleging Avandia causes heart attacks, said Paul Kiesel, a lawyer for former users. The accord...
More perspectives...
From rss.biospace.com
()
Overall, Glaxo's U.S. sales declined 5% for 2011, excluding the effects of currency exchange, partly because of generic competition for herpes ... television ads for erectile-dysfunction drug Levitra out of respect for the sensitivities of TV viewers.
From api.bing.com
()
- GlaxoSmithKline plc's CEO Discusses Q4 2011 Results (api.bing.com)
I return to the topic of GlaxoSmithKline (GSK.L) following its 2011 results and because I am thinking of buying it for the £10,000 portfolio based on Citywire Top Stocks®. Some think this focus on big, blue chips is a bit boring, but I think ...
From api.bing.com
()
- GSK Upbeat on Solid Results - Interviews with CEO and CFO (api.bing.com)
Rottenstein Law Group Is Encouraged by GlaxoSmithKline’s Settlement of 20,000 Lawsuits Over Its Diabetes Drug Avandia
I want to know what is in the drug that the FDA recalled it is called DIGITEC or digoxin?
Avandia Mediation Nets Settlement for 20,000 Heart Attack Lawsuits
Settlement Reached for 20,000 Avandia Lawsuits
Avandia (Rosiglitazone) increases risk Heart Attack & Stroke
Overview
The diabetes pill Avandia may cause significant heart risks. The FDA is now investigating and news is pouring out about the drug.
Avandia, sold by the British company GlaxoSmithKline PLC, is a blockbuster medication used to treat Type 2 diabetes, the most common form of the disease. More than 6 million people worldwide have taken the drug...more
The diabetes pill Avandia may cause significant heart risks. The FDA is now investigating and news is pouring out about the drug.
Avandia, sold by the British company GlaxoSmithKline PLC, is a blockbuster medication used to treat Type 2 diabetes, the most common form of the disease. More than 6 million people worldwide have taken the drug, whose U.S. sales topped $2.2 billion last year.
Avandia, sold by the British company GlaxoSmithKline PLC, is a blockbuster medication used to treat Type 2 diabetes, the most common form of the disease. More than 6 million people worldwide have taken the drug, whose U.S. sales topped $2.2 billion last year.
Sorted by: Top Rated
